Synthetic receptors with antibody-like binding affinities.
Antibodies are critical reagents in biological research and are increasingly being developed as therapeutic agents. They typically exhibit very high affinity and selectivity for their ligands. Synthetic protein-binding agents rarely achieve the combination of high affinity and selectivity for their target protein that is typical of a good antibody. However, significant efforts are underway to develop a new generation of protein ligands with improved properties. This article reviews progress towards this goal and suggests fruitful strategies for future research.
Kodadek
Thomas
T
Departments of Chemistry & Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, USA. kodadek@scripps.edu
D000818:Animals; D000906:Antibodies / Q000737:chemistry*; D006801:Humans; D008024:Ligands; D010455:Peptides / Q000737:chemistry; D054852:Small Molecule Libraries
D000906:Antibodies; D008024:Ligands; D010455:Peptides; D054852:Small Molecule Libraries